Mirum Pharmaceuticals Statistics
Total Valuation
MIRM has a market cap or net worth of $4.82 billion. The enterprise value is $4.76 billion.
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, after market close.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRM has 51.68 million shares outstanding. The number of shares has increased by 4.69% in one year.
| Current Share Class | 51.68M |
| Shares Outstanding | 51.68M |
| Shares Change (YoY) | +4.69% |
| Shares Change (QoQ) | +14.61% |
| Owned by Insiders (%) | 1.36% |
| Owned by Institutions (%) | 99.68% |
| Float | 44.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.76 |
| Forward PS | 7.96 |
| PB Ratio | 16.39 |
| P/TBV Ratio | 80.14 |
| P/FCF Ratio | 108.77 |
| P/OCF Ratio | 107.86 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 107.49 |
Financial Position
The company has a current ratio of 3.31, with a Debt / Equity ratio of 1.09.
| Current Ratio | 3.31 |
| Quick Ratio | 3.01 |
| Debt / Equity | 1.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | 7.19 |
| Interest Coverage | -2.91 |
Financial Efficiency
Return on equity (ROE) is -15.81% and return on invested capital (ROIC) is -4.50%.
| Return on Equity (ROE) | -15.81% |
| Return on Assets (ROA) | -3.60% |
| Return on Invested Capital (ROIC) | -4.50% |
| Return on Capital Employed (ROCE) | -6.69% |
| Revenue Per Employee | $1.47M |
| Profits Per Employee | -$128,643 |
| Employee Count | 322 |
| Asset Turnover | 0.65 |
| Inventory Turnover | 4.15 |
Taxes
In the past 12 months, MIRM has paid $593,000 in taxes.
| Income Tax | 593,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +98.66% in the last 52 weeks. The beta is 0.49, so MIRM's price volatility has been lower than the market average.
| Beta (5Y) | 0.49 |
| 52-Week Price Change | +98.66% |
| 50-Day Moving Average | 75.44 |
| 200-Day Moving Average | 62.05 |
| Relative Strength Index (RSI) | 75.13 |
| Average Volume (20 Days) | 734,400 |
Short Selling Information
The latest short interest is 8.36 million, so 16.18% of the outstanding shares have been sold short.
| Short Interest | 8.36M |
| Short Previous Month | 7.37M |
| Short % of Shares Out | 16.18% |
| Short % of Float | 18.93% |
| Short Ratio (days to cover) | 10.24 |
Income Statement
In the last 12 months, MIRM had revenue of $471.79 million and -$41.42 million in losses. Loss per share was -$0.84.
| Revenue | 471.79M |
| Gross Profit | 377.04M |
| Operating Income | -41.79M |
| Pretax Income | -40.83M |
| Net Income | -41.42M |
| EBITDA | -17.57M |
| EBIT | -41.79M |
| Loss Per Share | -$0.84 |
Full Income StatementBalance Sheet
The company has $375.55 million in cash and $318.76 million in debt, with a net cash position of $56.78 million or $1.10 per share.
| Cash & Cash Equivalents | 375.55M |
| Total Debt | 318.76M |
| Net Cash | 56.78M |
| Net Cash Per Share | $1.10 |
| Equity (Book Value) | 292.05M |
| Book Value Per Share | 5.69 |
| Working Capital | 370.22M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $44.69 million and capital expenditures -$374,000, giving a free cash flow of $44.32 million.
| Operating Cash Flow | 44.69M |
| Capital Expenditures | -374,000 |
| Free Cash Flow | 44.32M |
| FCF Per Share | $0.86 |
Full Cash Flow StatementMargins
Gross margin is 79.92%, with operating and profit margins of -8.86% and -8.78%.
| Gross Margin | 79.92% |
| Operating Margin | -8.86% |
| Pretax Margin | -8.65% |
| Profit Margin | -8.78% |
| EBITDA Margin | -3.72% |
| EBIT Margin | -8.86% |
| FCF Margin | 9.39% |
Dividends & Yields
MIRM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.69% |
| Shareholder Yield | -4.69% |
| Earnings Yield | -0.86% |
| FCF Yield | 0.92% |
Analyst Forecast
The average price target for MIRM is $97.55, which is 4.59% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $97.55 |
| Price Target Difference | 4.59% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 25.80% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIRM has an Altman Z-Score of 2.75 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.75 |
| Piotroski F-Score | 4 |
